YU295A - Postupci za sprečavanje degradacije proteina c - Google Patents

Postupci za sprečavanje degradacije proteina c

Info

Publication number
YU295A
YU295A YU295A YU295A YU295A YU 295 A YU295 A YU 295A YU 295 A YU295 A YU 295A YU 295 A YU295 A YU 295A YU 295 A YU295 A YU 295A
Authority
YU
Yugoslavia
Prior art keywords
apc
procedures
protein degradation
preventing protein
autodegradation
Prior art date
Application number
YU295A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
F.W. Prouty
J. Secnik
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22650141&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU295(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of YU295A publication Critical patent/YU295A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
YU295A 1994-01-05 1995-01-04 Postupci za sprečavanje degradacije proteina c YU295A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17783294A 1994-01-05 1994-01-05

Publications (1)

Publication Number Publication Date
YU295A true YU295A (sh) 1997-09-30

Family

ID=22650141

Family Applications (1)

Application Number Title Priority Date Filing Date
YU295A YU295A (sh) 1994-01-05 1995-01-04 Postupci za sprečavanje degradacije proteina c

Country Status (29)

Country Link
EP (2) EP0662513B1 (fi)
JP (1) JP3778588B2 (fi)
KR (1) KR950032287A (fi)
CN (1) CN1109891A (fi)
AT (1) ATE201045T1 (fi)
AU (1) AU1003195A (fi)
BR (1) BR9500017A (fi)
CA (1) CA2139468C (fi)
CO (1) CO4600680A1 (fi)
CZ (1) CZ1395A3 (fi)
DE (2) DE69520844T2 (fi)
DK (1) DK0662513T3 (fi)
ES (1) ES2156190T3 (fi)
FI (1) FI115635B (fi)
GR (1) GR3036277T3 (fi)
HU (1) HUT70465A (fi)
IL (1) IL112236A (fi)
LU (2) LU90993I2 (fi)
NL (1) NL300108I2 (fi)
NO (2) NO320157B1 (fi)
NZ (1) NZ270271A (fi)
PE (1) PE43995A1 (fi)
PL (1) PL180703B1 (fi)
PT (1) PT662513E (fi)
RU (1) RU2167936C2 (fi)
SI (1) SI0662513T1 (fi)
UA (1) UA39178C2 (fi)
YU (1) YU295A (fi)
ZA (1) ZA9514B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998048818A1 (en) * 1997-04-28 1998-11-05 Eli Lilly And Company Activated protein c formulations
EP1557463A1 (en) * 1997-04-28 2005-07-27 Eli Lilly & Company Improved methods for processing activated protein C
US6630137B1 (en) 1997-04-28 2003-10-07 Eli Lilly And Company Activated protein C formulations
US7204981B2 (en) 2000-03-28 2007-04-17 Eli Lilly And Company Methods of treating diseases with activated protein C
WO2001089558A2 (en) 2000-05-24 2001-11-29 Eli Lilly And Company Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT402262B (de) * 1991-06-20 1997-03-25 Immuno Ag Arzneimittel enthaltend aktiviertes protein c

Also Published As

Publication number Publication date
EP1087011A2 (en) 2001-03-28
SI0662513T1 (en) 2001-10-31
NO950018D0 (no) 1995-01-03
NO2006006I1 (no) 2006-05-15
DE69520844T2 (de) 2001-11-08
NL300108I1 (nl) 2003-02-03
CZ1395A3 (en) 1995-07-12
DE10299053I2 (de) 2004-04-01
PE43995A1 (es) 1995-12-15
LU90992I2 (fr) 2003-02-18
JP3778588B2 (ja) 2006-05-24
UA39178C2 (uk) 2001-06-15
NZ270271A (en) 1996-07-26
CO4600680A1 (es) 1998-05-08
IL112236A (en) 1999-12-31
CN1109891A (zh) 1995-10-11
PL180703B1 (pl) 2001-03-30
DE10299053I1 (de) 2003-05-22
RU95100178A (ru) 1997-03-27
FI950044A0 (fi) 1995-01-04
ATE201045T1 (de) 2001-05-15
IL112236A0 (en) 1995-03-30
JPH07206704A (ja) 1995-08-08
CA2139468C (en) 2007-08-21
AU1003195A (en) 1995-07-13
NL300108I2 (nl) 2003-06-02
KR950032287A (ko) 1995-12-20
PT662513E (pt) 2001-08-30
DK0662513T3 (da) 2001-05-28
FI115635B (fi) 2005-06-15
EP1087011A3 (en) 2002-02-06
ES2156190T3 (es) 2001-06-16
FI950044A (fi) 1995-07-06
GR3036277T3 (en) 2001-10-31
CA2139468A1 (en) 1995-07-06
EP0662513A1 (en) 1995-07-12
ZA9514B (en) 1996-07-03
HU9500021D0 (en) 1995-03-28
EP0662513B1 (en) 2001-05-09
HUT70465A (en) 1995-10-30
NO320157B1 (no) 2005-11-07
BR9500017A (pt) 1995-10-03
DE69520844D1 (de) 2001-06-13
RU2167936C2 (ru) 2001-05-27
NO950018L (no) 1995-07-06
LU90993I2 (fr) 2003-02-18
PL306671A1 (en) 1995-07-10

Similar Documents

Publication Publication Date Title
BR9407047A (pt) Processo para separaçao de uma proteina de uma soluçao aquosa de proteinas
EA199900980A1 (ru) Улучшенные способы приготовления активированного белка с
DE69432035D1 (de) Saccharinderivate als proteolytische Enzyminhibitoren
EA200100957A1 (ru) Композиция на основе аскорбиновой кислоты и способ лечения стареющей или поврежденной кожи
DE69031656T2 (de) Saccharinderivate zur verwendung als proteolytische enzyminhibitoren sowie verfahren zur herstellung
NO2006006I1 (no) Aktivert protein C
DE69011622D1 (de) Verwendung von geschützten Aminosäuren in Futtermitteln für Schafe.
DE69227805T2 (de) Verwendung von Tri-n-Butylphosphat bei niedrigem pH in Lösungen von biologisch aktiven Proteinen für eine verbesserte viruzide Wirkung
GR1001480B (el) Ενζυμικά σκευάσματα περιέχοντα παπαϊνη ή χυμο?ρυψίνη και μέ?οδοι μόνιμης ενζυμικής αποτρίχωσης.
ATE220678T1 (de) Verfahren zur gewinnung von hämin aus schlachtblut
TH19245A (th) วิธีป้องกันการสลายของโปรตีนซี
IT8464501A0 (it) Procedimento ed impianto per il trattamento di carniccio di conceria per recuperare le frazioni riutilizzabili come grasso, proteine, sali inorganici, acque alcalino solfuree per riduzione scleroproteine.